Although nanorobots may play critical roles for many applications in the human body, such as targeting tumoral lesions for therapeutic purposes, miniaturization of the power source with an effective onboard controllable propulsion and steering system have prevented the implementation of such mobile robots. Here, we show that the flagellated nanomotors combined with the nanometer-sized magnetosomes of a single magnetotactic bacterium can be used as an effective integrated propulsion and steering system for devices, such as nanorobots, designed for targeting locations only accessible through the smallest capillaries in humans while being visible for tracking and monitoring purposes using modern medical imaging modalities such as magnetic resonance imaging. Through directional and magnetic field intensities, the displacement speeds, directions, and behaviors of swarms of these bacterial actuators can be controlled from an external computer.
Introduction
The first demonstration of an untethered device propelled and navigated in the blood vessel of a living animal has been recently reported (Martel et al. 2007) . In this demonstration, being part of a project known as Magnetic Resonance Submarine (MR-Sub), propulsion force was induced on a ferromagnetic core by magnetic gradients produced by the three orthogonal imaging coils of a clinical Magnetic Resonance Imaging (MRI) system. In this type of configuration, external hardware is required to propel untethered objects or nanorobots 1 .
To move or actuate untethered devices such as micro-or nanorobots without the need for external hardware dedicated to propulsion, artificial molecular machines built through the assembly of a discrete number of molecular components designed to jointly carry out a specific action have been proposed (Drexler 1992) . As such, nanomotors found in nature, such as flagellated propulsion mechanisms of bacteria, have inspired many researchers trying to mimic them using modern engineering development methods Sitti 2005, 2006) . A recent example is an artificial flagellum in the form of a nanocoil that has been propelled using a rotating magnetic field (Bell et al. 2007 ), a technique inspired from a principle theoretically described previously in Honda et al. (1999) . However, again due to technological constraints including, but 1. Nanorobots are defined here as micro-entities operating under feedback control and relying on parts of less than around 100 nm used to implement new embedded functionalities. not limited to, embedding a power source, this configuration still relies on external hardware for propulsion. So far, nobody has been successful in developing an autonomous (i.e. without the need for an outside power source for propulsion) engine capable of sufficient thrust for practical applications.
Instead of developing such autonomous nanomotors, we have proposed another strategy (Martel 2005 ) that includes the use and integration of bacteria and more specifically Magnetotactic Bacteria (MTB) (Blakemore 1975) , using their molecular motors as a means of propulsion or bio-actuation for nanorobots or other micro-scale entities and recognizing their potential for applications in human blood vessels . This project, dubbed MTB-based robot (MTBot), aims at integrating and controlling MTB for developing new generations of nanorobots (bacterial nanorobots) for various applications, a new field of research that could be referred to as bacterial nanorobotics.
The molecular motor embedded in flagellated bacteria measures less than 300 hydrogen atoms across, and has a rotor that can operate at 6,000 to 17,000 revolutions per minute (rpm). With the flagellum acting as a propeller being attached to the rotor, this rotor usually reaches 200 to 1,000 rpm. This rotary engine composed of proteins is powered by a flow of protons, which makes it particularly attractive in implementations where the availability of electrical power is very limited, as is often the case for miniature untethered robots.
The validation through experimental data demonstrating the use of a bacterium to push, transport and manipulate a micro-object and the actuation of micro-or nanorobots with precise control over the displacement of the bacterium was first reported in . This was a significant improvement over the random (uncontrolled) motions of an auto-mobile microchip with bacteria attached previously observed and reported in Darnton et al. (2004) . This demonstration with uncontrolled directional motions was replicated later with chemically stop/resume motion control (Behkam and Sitti 2007) and phototaxis-based stop/resume motion control (Steager et al. 2007 ). In the former approach, the introduction of copper ions or ethylenediaminetetraacetic acid in the liquid medium has been proposed. In the latter case, ultraviolet light was used. Although these proposed methods allow the bacterial motion to be stopped or resumed at will, still no directional control was achieved.
More interesting is the fact that our proposed method based on MTB can stop and resume motion at will while controlling the displacement speed from an external computer and without the use of chemical agents, as described in more detail later in this paper.
Although nobody has succeeded in controlling the direction of bacteria chemically, there are questions about the viability of using a chemical approach for controlling bacterial actuation for nanorobots. Indeed, there are two major drawbacks in using a chemical approach to control bacterial actuators. Firstly, it is not appropriate for applications in many en- vironments and particularly for operations in the human body. Secondly, chemical control is not compatible with electronic circuits. This lack of interface with electronics and softwarebased algorithms/programs may represent a major obstacle to the implementation of fully controllable nanorobots. As for phototaxis, it is not applicable in many environments including regions deep inside the human body.
On the contrary, the swimming direction of MTB can be controlled by inducing a torque on a chain of nanoparticles called magnetosomes. This torque can be induced from a small-directional magnetic field. In turn, this local-directional magnetic field can be generated by passing an electrical current through a conductor in the vicinity of the bacteria, hence providing a suitable, reliable and compatible interface with electrical control/monitoring systems and computers.
Controllable Bacterial Actuators
A photograph of a MC-1 MTB is depicted in Figure 1 . Although most people would see it as a simple living organism, from an engineering point of view this bacterium can be considered as a sophisticated actuator with an embedded control interface.
As depicted in Figure 1 , the cell of the MC-1 bacterium is spherical in shape and measures approximately 2 1m in diameter. Each cell has two flagella bundles providing a thrust force exceeding 4 pN. This value is relatively high compared to other flagellated bacteria with a typical thrust force in the range of 0.3-0.5 pN. This allows the MC-1 bacteria to swim in water at room temperature and without load at speeds often exceeding 200 1m s 21 . This is a very high speed when we know that the swimming speeds of most flagellated bacteria in the same conditions are 330 1m s 21 . Maximum displacement speeds of 3300 1m s 21 in water at room temperature and corresponding to 3150 times the cell length for a relatively large proportion of the bacteria samples have also been recorded experimentally by our group.
Unlike most bacteria, which are based on chemotaxis to detect nutrient gradients and hence influence their motility (Berg and Brown 19721 Ford et al. 19911 Armitage 1992) , the direction of displacement of MTB with their chain of magnetosomes, which are membrane-based nanoparticles of a magnetic iron, although influenced by chemotaxis and aerotaxis, are also influenced by magnetotaxis (Denham et al. 19801 Frankel and Blakemore 19801 Debarros et al. 1990 ). However, when subjected to a magnetic field slightly higher than the Earth's magnetic field of 0.5 Gauss, the directional motions of these MTB become mainly influenced by magnetotaxis and therefore fully controllable by electronics and computers ).
Choice of MTB
Until now, all MTB that have been studied are motile by means of flagella and as such they could theoretically be considered for the implementation of actuation and propulsion systems for micro-or nanorobots. Practically, although several types of MTB exist and can be found all over the world, the selection process for the type of MTB to be used in robotics is still constrained since only a few types can be cultured in artificial or laboratory conditions. Most cultured strains belong to the genus Magnetospirillum (M.) and include species such as: M. magnetotactium strain MS-1 (Blackmore et al. 1979)1 M. magneticum strain AMB-1 (Matsunaga et al. 1991 )1 M. gryphiswaldense (Schleifer et al. 1991 )1 the marine vibrios strains MV-1 (Bazylinski et al. 1988) and MV-21 a marine coccus, strain MC-1 (Delong et al. 1993 )1 a marine spirillum, strain MMS-1 (formerly MV-4) (Meldrum et al. 1993 )1 and sulfate-reducing rod-shaped MTB known as the Desulfovibrio magneticus strain RS-1 (Sakaguchi et al. 1993) . However, when interfaced to micro-or nanorobots, higher swimming speeds typically become one of the key factors for selecting the right MTB. In general, the magnetotactic spirilla are at the slower end (2100 1m s 21 ) while the magnetotactic cocci are at the faster end (3100 1m s 21 ). As such, the strain of MC-1 cells 2 seems to be a good choice and has been selected in this particular study (peak speeds approaching 300 1m s 21 have been measured experimentally by our group as stated earlier). If the size of the MTB is an important aspect to consider, the MV-4 bacterium is the smallest with 2. The MC-1 bacteria used in this study were cultivated at the NanoRobotics Laboratory at EPM in incubators using special controlled procedures and environmental conditions. a length of 30.5 1m compared with 32 1m for the MC-1, but the choice for a smaller cell is at the cost of slower swimming speeds (in the range of 330-80 1m s 21 ). Both previous types have two FBs on one side of the cell and they are classified as polar MTB. Polar MTB swim persistently in one direction along the magnetic field. Polar MTB, unlike axial MTB, are generally more suitable for controlled untethered devices, such as nanorobots, since they are usually more predictable when controlling their swimming directions. For instance, some cells have FBs on both ends. These MTB swim in both directions along the magnetic field lines with frequent reversals of swimming directions with approximately the same number of bacteria swimming in each direction. Because of this behavior, they are classified as axial MTB. The Magnetospirillum gryphiswaldense bacterium is one example with a length varying between 31-3 1m, a width of 30.5 1m and swimming speeds in the range of 340-80 1m s 21 .
Propulsion and Terminal Velocity
The shape of the bacterial flagellum acting like a propeller consists of a 20 nm-thick hollow tube. It has a helical shape with a sharp bend outside and next to the outer membrane. Put together, they form what looks like a hook where a shaft runs between the hook and the basal body. The shaft then passes through protein rings in the cell's membrane that act as bearings. Counter-clockwise rotations of a polar flagellum thrust the cell forward.
For propulsion or transport purposes, the thrust force provided by each MTB is the key factor to consider in the evaluation of the terminal velocity. The terminal velocity v T of a single MC-1 MTB can then be estimated (discounting the effect of the trailing flagella and assuming a constant rotational speed of the flagellum or a constant proton flux in the molecular motor) from Stokes' equation as
where, in our particular case subjected to our experimental and cultivation conditions, 487510 212 4 F T 4 480510 212 N with 6 4 180 mPa6s in water at 20 7 C represent the thrust force and the viscosity of the medium, respectively, while d 8 2 5 10 26 m represents the diameter of the cell when unloaded. Note that the diameter of the entire moving body could increase when loaded. Similar to tolerances for mechanical or electrical parts, the engineers must cope with tolerances in terminal velocities for MTB and as for engineered parts, a pre-selection will be essential if precise specifications are required in the implementation. The initial swimming speed distribution of the unloaded and unselected (i.e. without a priori selection processes) MC-1 MTB in an aqueous medium at room temperature is depicted in Figure 2 . The swimming speeds from a significantly large sample of MC-1 MTB have been measured in our laboratory with a video camera (Axiocam MRm from Carl Zeiss) mounted on an optical microscope (Zeiss Axio-Imager) in reflection-mode microscopy using dark-field illumination using the following settings: a magnetic field of 20 Gauss1 an objective Long Distance (LD) Epiplan of 205.
Effect of Body Temperature on the Terminal Velocity
Our experimental results show that an increase of the temperature level T will influence the terminal velocity of MC-1 MTB. When MC-1 MTB are considered for medical nanorobots designed for operations in the human body where T 4 37 7 C, the experimental results as depicted in Figure 3 show that the terminal velocity of MC-1 MTB will decay for a duration of 340 minutes. Although the viscosity of blood at such a temperature is 3-4 mPa6s, considering that the cell size of the MC-1 MTB is smaller than a single red cell, the viscosity of plasma, which is approximately equivalent to water, has been considered.
Loading MTB while Maintaining Maximum Velocity
In this particular context, MTB can be used to propel a load that may take various forms such as nano-or microparticles, carrying therapeutic agents or acting as biosensors, to larger objects typically capable of more sophisticated functions for the implementation of a more technologically advanced nanorobot (e.g. André and Martel 2006) . Figure 4 shows four loading strategies where MTB can be used for propulsion. Fig. 3 . Effect of the temperature on the swimming speed of unloaded MC-1 MTB in blood at 37 7 C. Although several loading strategies can be applied, for operations such as the delivery of therapeutic agents to a tumoral lesion requiring transitions through capillary sections of the human microvasculature, the method showed in Figure 4 was validated by our group in an experiment that aimed at loading fluorescent cell penetrating peptides (FITC-LC-Antennapedia -Anaspec, San Jose, CA 95131) inside the MC-1 cell. Although promising, more work needs to be done before it becomes an effective means of delivery for such applications. Nonetheless, this approach is still considered for future improvement as a means of targeting cytotoxic agents or radioactive substances.
For many target delivery applications in the microvasculature, the method depicted in Figure 4 (b) is quite attractive. Here, biodegradable polymeric nanoparticles for instance with an overall diameter of 3150 nm can be attached to the MTB cell. The use of antibodies 3 is one practical and efficient method to attach such nanoparticles in this particular case. The size of the nanoparticles chosen is large enough to contain sufficient therapeutic agent while being small enough not to add significant drag force to the cell.
Capillary Wall Effect on Bacterial Nanorobots
According to Stokes' law, the drag force D in low Reynolds number (Re21) hydrodynamics as encountered in the human microvasculature can be derived from Equation (1) and computed as D 4 356d4 T 9 0 Re 18 (2) Such that the opposing drag force is then proportional to the viscosity of the medium, the diameter of the moving object (considering the cell's size combined with the load), and the velocity of the object (Kundu and Cohen 2002) (being the bacterial carrier or nanorobot) without a noticeable effect from the shape of the object itself.
Although the size or diameter of each bacterial carrier or nanorobot could theoretically be increased with additional loads, hence increasing drag force, other factors influencing the speed of the MTB in the particular environment where they operate must also be taken into account. For instance, when moving or navigating in smaller capillaries, the drag force acting against the spherical MC-1 cell is a function of 9 4 dd C , which is the ratio between d as defined earlier and the diameter of the capillary d C , a phenomenon also known as the wall retardation effect (Fidleris and Whitmore 1961) . When the diameter ratio approaches unity, the wall effect becomes predominant. In the worst case, we expect a min d C 8 4 to 5 5 10 26 m for the small capillaries in humans including blood vessels created by angiogenesis, i.e. vessels used prior to reaching the tumoral regions for applications such as target chemotherapies. Hence a worst case of 9 8 085 or slightly higher if nanoparticles are loaded would be expected as a maximum ratio for the 3. These antibodies specific to the MC-1 cells have already been developed and tested successfully at the NanoRobotics Laboratory at EPM. Fig. 5 . Swimming speeds of the MC-1 cells (with a velocity of 223 1m s 21 when not subject to the wall effect) for different microchannel widths. The graph shows that the velocity in channel widths similar to the narrower capillaries decrease much less than the theoretical model applied to non-biological objects. Although this needs further investigation, this may suggest a thrust force compensation of the MC-1 bacteria when swimming in such conditions. MC-1 bacterial nanorobots. From classical theory, the wall effect on the velocity of the bacteria v can be estimated (Francis 19331 Fidleris and Whitmore 1961) as 4 1 1 2 9 1 2 084759
where v is the velocity of the bacteria in open space. When 4 4 256825 1m s 21 (the global value estimated from the experimental data, see Figure 2 ), the swimming speed of the bacteria should decrease from 256.25 down to 48.38 1m s 21 .
It is interesting to note that our preliminary experimental data depicted in Figure 5 show that the MC-1 cells swim much faster in a narrow channel when submitted to the wall effect than the speed predicted using Equation (3). Indeed, although the theoretical estimation predicts that the swimming speed should decrease by approximately 81% (from 256.25 down to 48.38 1m s 21 ), when the width of the channel shrinks from 12 to 4 1m. The data in Figure 5 were recorded with a group of 30 bacteria under a directional field of 20 Gauss at constant environmental conditions and at room temperature. The bacteria were taken from a fresh culture. The data recorded under optical microscopy show that compared to a microbead of the same size and submitted to the same force observed from the MC-1 cells in open space, that the bacteria still swim faster in smaller diameter channels.
The results presented in Figure 5 are in accordance with similar observations in a previous study (Mitchell et al. 1995) . This may suggest that the thrust force of bacteria could increase significantly to compensate for attenuating forces such as the wall effect, although more experiments are needed.
In other words, it may be possible (although it is too early to confirm it) that the MC-1 cell may compensate such opposing force by increasing the proton flux in order to increase the rotational rate of the flagella, but this assumption needs further investigation. However, if this is the case, there will be a maximum limit in the flow of protons and such additional compensation may end up being non-significant in this particular case. Nonetheless, such additional proton flux, which has been recorded in previous experiments under certain conditions, is most likely to shorten the lifespan of the bacteria when no nutrients are available. Hence, considering the relatively short lifespan of the MC-1 MTB in more severe conditions such as the one plotted in Figure 3 , this may not be suitable in this particular context.
It is then interesting to notice that since d 8 21m for the MC-1 bacterium, we will have an ideal worst case of 9 8 085 in the smallest capillaries, while providing some room to attach nanoparticles at the surface of the cell without significantly increasing wall retardation effect.
Controlling the Velocity of Bacterial Nanorobots
As depicted in Figure 1 and mentioned earlier, each MTB synthesizes in their cell a chain of membrane-based nanoparticles called magnetosomes. Besides being used for controlling their swimming directions, these magnetosomes can also be used to control their swimming speeds with any values between and including zero and their maximum swimming speeds. This is shown in Figure 6 .
The results plotted in Figure 6 show that not only genetic modifications, but also the conditions of culture alone can be used to adjust the characteristics of the MTB. A DC magnetic field allows us to control the velocity of bacterial nanorobots while offering an interface with electrical computing systems without the use of chemical agents. Although the DC magnetic field is not required to achieve maximum velocities, which is a really positive feature in other applications relying on bacterial nanorobots, reducing or even stopping the movement of bacterial nanorobots may be highly suitable in some particular applications including, but not limited to, direct medical targeting interventions inside the human body. For instance, for navigating nanorobots directly towards a pre-defined target inside the human body, a guiding system must be implemented. Without such guiding system, such nanorobots would get lost in the maze that represents the human vascular network, which is constituted of close to 100,000 km of blood vessels.
As depicted in Figure 6 , to stop a single or an entire swarm of bacterial nanorobots without chemical agents, a DC mag- netic field with sufficient magnitude must then be applied. Although further investigations need to be done, the experimental results plotted in Figure 6 suggest that the 1.5 T or higher DC magnetic fields typically found in the bore of modern clinical MRI systems would stop the swimming movement of such bacterial nanorobots, allowing easier and more accurate determination of their position in the human body. Controlled speeds of the bacterial nanorobots can then be resumed in a special configuration as discussed later in this paper.
Tracking Magnetotactic Bacteria-based Nanorobots with Magnetic Resonance Imaging
As mentioned earlier, being able to track such medical nanorobots inside the human body is essential for applications involving direct targeting. The magnetosomes embedded in each MC-1 MTB as shown in Figure 7 are Fe 3 O 4 single magnetic domain crystals of a few tens of nanometers in size. Similar to nanoparticles used for MRI contrast agents, magnetosomes cause a local distortion of the magnetic field inside the bore of a clinical MRI system. The local magnetic field distortion from each magnetosome can be approximated at a point P of coordinate r (x, y, z) by that of a magnetic dipole as described by Equation (4) 
where 1 0 4 4510 27 H6m 21 is the permeability of free space. For a uniformly magnetized object, the dipolar magnetic moment (A6m 2 ) is given by m 4 4 3 5a 3 M SAT (5) Fig. 7 . Magnetic field lines (Tesla) generated by a magnetosome chain superimposed on an electron microscopy image of the bacterium. In this simulation, we consider the presence of 11 magnetosomes with a mean diameter of 70 nm. The distance between the magnetosomes is 20 nm. The saturation magnetization for magnetite (0.6 T) is considered since at the MRI field of 1.5 T, the magnetite chain is saturated.
where M S AT is the saturation magnetization of the object, and a its radius (m) considering a spherical shape. A numerical simulation of a single bacterium magnetic field plotted over an electron microscopy image is depicted in Figure 7 . The simulation results assume 11 aligned magnetosomes, each with a diameter of 70 nm. The magnetosome chain significantly disturbs the local magnetic field. As depicted in Figure 8(a) , the field perturbation is significant near the bacterium with values greater than 100 ppm and decreases further away from the bacterium. This is quite significant for our application considering that the accepted homogeneity level of a modern MRI clinical scanner is approximately 5 ppm over a 50 cm diameter spherical volume at 1.5 T. These perturbations mostly affect the spin-spin (T2) relaxation times as depicted in Figure 8(b) , where several concentrations of MTB were imaged using a fast spin echo sequence. These results suggest that MRI could potentially be used to track MTB in 3D inside the human body, providing a superior imaging modality compared to existing medical imaging methods for this particular application. These images were run with a Siemens Avanto 1.5 T clinical scanner using a wrist antenna. The sequence parameters are: TR/TE = 5,620/127 ms, a slice thickness of 20 mm, and pixel spacing of 0.254 mm. Fig. 8. (a) Simulation of the local magnetic field perturbation for a uniformly distributed concentration of MTB. The distance between the MTB is 25 1m corresponding to a concentration of approximately 10 7 cells ml 21 . (b) Turbo spin echo sequence imaging of several samples of MTB of different concentrations. From 1 to 8 the concentrations are 0, 0.19, 0.30, 0.51, 0.73, 0.84, 0.90, 1 5 10 8 cells ml 21 . These experimental data confirm the possibility of tracking the MTB using MRI. The sequence parameters are TR/TE = 5,620/127 ms, the Echo Train Length (ETL) = 277 5125408 pixels and a spatial resolution of 0.254 mm. When the concentration of MTB increases, the transverse relaxation rate increases leading to a decrease of the signal intensity.
Steering Control
A magnetic field will exert a torque on a ferromagnetic material such as magnetite or on a material with diamagnetic anisotropy. Only ferromagnetic or superparamagnetic crystals with a length below 35 nm are able to produce a response to a field as weak as the geomagnetic field (0.5 Gauss) that is detectable against thermal motion. Magnetosomes within the permanent single domain size range are uniformly magnetized providing the maximum magnetic dipole moment per unit volume. When arranged in a chain, as is the case for the MC-1 MTB, magnetostatic interactions between the single domain crystals cause the magnetic moments to spontaneously orient parallel to each other along the direction of the chain, resulting in a permanent magnetic dipole for the entire chain with a magnetization approaching its saturation value at 0.6 T. Hence, the magnetite chain in MTB, acting like a compass needle, can be rotated by a magnetic field because of the torque exerted on their magnetite particles. In other words, this chain of magnetosomes imparts to the MTB a magnetic moment that generates sufficient torque so that the bacteria can align themselves to magnetic field lines. This is referred to as magnetotaxis. Some examples performed by our group of computer-based direc- tional control, based on magnetotaxis of MTB recorded using optical microscopy, are depicted in Figure 9 .
The swimming direction of MTB is influenced not only by magnetotaxis, but also by aerotaxis and chemotaxis. Aerotaxis is defined as the movement of an organism, especially a bacterium, toward or away from air or oxygen while chemotaxis is defined as directed movement of a cell or organism toward (or away from) a chemical source. Although at lower magnetic field intensities, i.e. around the geomagnetic field of 0.5 Gauss, magnetotaxis has an influence on the swimming directions of MTB, previous experiments conducted by our group show that a higher magnetic field with a minimum value of approximately 3 Gauss (or even less) provides the best control and response of the MTB from directional commands generated by an electrical source by making magnetotaxis the predominant factor over chemotaxis and aerotaxis.
With regards to thermal noises, it has been reported and estimated that the magnetic moment for the smaller organisms are 180 5 10 215 Am 2 , with a corresponding magnetic energy in the geomagnetic field of 50 1T is 580 5 10 220 J. This value is already a factor of ten higher than the thermal energy at room temperature. Hence, in a controlled environment (where the effects of aerotaxis and chemotaxis are negligible), the average orientation of the cell along the magnetic field as it swims is determined by the ratio of magnetic to thermal energy. Hence for a ratio of 10, the average projection of the magnetic dipole on the magnetic field is 0.9, meaning that the MTB will migrate along the field at 90% of its forward speed. Hence, by increasing the intensity of the directional field up to a certain limit, more accurate directional control can be achieved.
In some instances, the combination of sensory information such as chemotaxis or aerotaxis with magnetotaxis to influence the motion of the MTB-based nanorobots may be suitable. For instance, polar magneto-aerotaxis keeps cells at the preferred oxygen concentration at the oxic-anoxic interface. This feature could potentially be integrated at a specific moment in the control protocol to enhance tumor targeting where a decrease in the oxygen concentration exists.
Effect of Vessel Geometries
When a swarm of MTB or bacterial nanorobots move in a given direction (see video extension 1) to deliver sufficient therapeutic compounds to a tumor, for instance, dispersion or loss in density of the agglomeration due to swimming speed variation among the MTB and inter-MTB interactions may occur over a relatively short time. Over time, such dispersion could reduce local field perturbations below the minimum threshold required for the swarm to be detectable inside the human body, depending on the limit in sensibility of the detection system and the imaging modality being used. Fortunately, the complex vessel network geometry can be exploited to maintain the grouping through successive small displacement segments.
Coercivity-based Control
In our particular context, coercivity H C is defined as the minimum field strength required for flipping the magnetic moment of a uniform magnetized (single domain) crystal from one stable direction to another. Hence, such coercivity could potentially be considered in the navigation protocol of the bacterial nanorobots to enhance targeting effectiveness in the human body. For instance, it has been reported that a magnetic pulse of higher intensity than H C induces a complete reversal of the magnetotactic direction (Kalmijn and Blakemore 1978) without affecting the viability of the cells (Hedges 1985) , a technique referred to as pulse re-magnetization. For MTB, we expect H C 8 30 mT (300 Gauss) as reported by Blakemore et al. (1985) and Mann et al. (1987) , for instance. This value can be increased up to an H max C which can be approximately twice the original H C using the pulse magnetization technique (Diaz Ricci et al. 1991) .
The effect of a pulse re-polarization on the percentage of re-polarized MC-1 cells from experimental data obtained by our group is depicted in Figure 10 . Once re-polarized (remagnetized), the bacteria will continue swimming in the same original direction until they reach an obstacle. When reaching an obstacle, the MTB will begin swimming in the reverse direction if re-polarized. Prior to reach an obstacle, the MTB's swimming speed is reduced according to the magnitude of the pulse and will resume the initial speed after the pulse. Moreover, our group also observed that when using a magnetic field with a magnitude of at least 3120 Gauss, the MTB will swim in the reverse direction when encountering an obstacle (with a sufficiently large surface), otherwise the MTB will continue swimming persistently towards the obstacle. This feature is presently considered as an enhancement to the navigation/control algorithm for increasing targeting effectiveness for bacterial nanorobots operating in the angiogenesis network.
Biocompatibility
For nanorobots operating in the blood vessels, biocompatibility is an important issue to consider. The degradation products of the non-pathogenic bacteria can have a cytotoxic effect at a relatively high concentration. Under 80 1l of bacteria solution (with a density of 5 5 10 4 cells/200 1l in a cell culture solution) in a 200 1l well, our preliminary tests showed that the cell viability is higher than 90%. The cell viability is increasing with exposure time, which indicates the non-cytotoxic effect of the bacteria at this volume. This cell viability assay also shows that the bacteria biocompatibility depends on the bacteria volume, hence imposing a limit on the quantity of bacterial nanorobots that can be presented in the body at any given time. Therefore, the number of bacterial nanorobots used should be high enough to deliver a sufficient amount of therapeutic agents with a density sufficient to be MR-trackable, while being lower than the cytotoxicity limit. Nonetheless, this issue needs further studies with bacteria degradation products analysis and haemocompatibility assays such as platelet adhesion, leukocytes activation and haemolysis assays. The results Fig. 11 . MC-1 bacterium versus propulsion/steering magnetic gradient coils for humans, showing the potential advantage of bacterial actuation for carriers or nanorobots navigating in smaller capillaries. The graph considers 50% Permendur (the highest magnetization saturation material) per unit volume to leave room for embedding therapeutic agents.
of these assays will give further insight through experimental data on the bacteria concentration, which can be used safely for in vivo assays.
Targeting Strategy
As in a naval force where a fleet of various types of combat platforms can provide more effective strategies against the enemy, several types of medical nanorobots may prove to be more effective for fighting tumors. For instance, slightly larger "embolization nanorobots" can be used to temporary reduce blood flow in capillaries and hence facilitating the steering of "targeting nanorobots" towards a tumor. Small-diameter blood vessels are presently not visible on any medical imaging systems, preventing effective path planning to reach the target. Hence, "scout nanorobots", acting as navigable MRI contrast agents, can also be used to gather information that will be used to plan the final attack. Figure 11 shows that bacterial nanorobots propelled by a single MC-1 cell may be advantageous over the induction of force on a ferromagnetic material for navigation in the blood vessels as demonstrated in vivo in Martel et al. (2007) for devices smaller than 32-3 1m in diameter. As the total volume dedicated to the ferromagnetic or superparamagnetic nanoparticles decreases, the total induced propulsion force is also significantly reduced.
Although blood flow velocities are lower in smaller diameter blood vessels compared to larger ones, additional magnetic gradient coils inside the MRI system must still be considered. However, as the magnetic gradients increase to compensate for smaller volumes of ferromagnetic materials, the coils begin to overheat. Hence, to prevent a shutdown of the system, which may result in tragic consequences for the patient, the time dedicated to propulsion and steering of the nanorobots must be decreased during the tracking/propulsion cycles to allow time for the coils to cool down. The limited time dedicated to steering or propulsion may impact in some situations targeting effectiveness. Even by using the best ferromagnetic materials available, such as Iron-Cobalt, for inducing the maximum force per volume unit, this may still remain an issue when navigating in the microvasculature. This limitation gets even worse when proven biocompatible materials that offer less propulsion power density, such as Iron-Oxide, are considered to avoid additional design complexities intended to prevent toxic Cobalt ions coming into direct contact with blood. As such, the molecular motor of the MC-1 bacterium can become very useful when operating in the microvasculature.
Similarly, although efficient in the microvasculature, the thrust force of MTB is insufficient to cope with the higher flow rates typically encountered in larger blood vessels. This may suggest the need for ferromagnetic carriers propelled and steered using magnetic gradients and designed to encapsulate and carry bacterial nanorobots past the arterioles, ideally located at the entrance to the capillary network. This is represented schematically in Figure 12 . Pre-synthesized biodegradable polymer or hyperthermia-based techniques used to elevate the temperature of embedded nanoparticles could be used as release methods. The same carrier could be used for temporary embolization (the embolization carrier in Figure 12 ) to facilitate targeting with MTB-based nanorobots. 
Robotic Platform
A basic diagram of a MRI-based robotic platform adapted for ferromagnetic and bacterial nanorobots is depicted in Figure 13 . Although such platforms rely on several software modules and algorithms, only the main hardware components are shown for simplicity.
A conventional clinical MRI system is upgraded with additional coils, represented in bold in Figure 13 with their respective Amplifiers Unit (AU). Although the encoding gradient coils are sufficient to propel larger ferromagnetic carriers or robots in the blood vessels, the additional 3D Steering Gradients Coils (SGC) are required to steer smaller ferromagnetic or superparamagnetic carriers or robots. Although other medical imaging platforms could be upgraded for navigating bacterial nanorobots and be implemented with much less complexity than with MRI, the use of MRI provides many advantages that may be worth the additional implementation and control complexity, such as the possibility for three-dimensional imaging inside the human body, enhanced tissue contrast, the lack of radiation, the presence of a large homogeneous magnetic field inside the bore of the MRI system that is sufficient to bring the magnetic material of the ferromagnetic robots to saturation, and the availability of MRI systems in clinics and hospitals making technology transfers and acceptance easier while reducing the cost of implementing the technology.
As depicted in Figure 13 , the use of bacterial nanorobots require the addition of 3D Steering Magnetic Coils (SMC) located just outside of the entrance of the MRI bore, at a location where the DC magnetic field of the MRI system is negligible and where a torque can be induced on the chain of magnetosomes embedded in the MTB. The entry/exit process provided by the mechanical table takes into account the control algorithms.
Summary and Conclusion
The real challenge in the development of medical micro-or nanorobots designed to operate in human blood vessels goes beyond the aspect of propulsion alone. In this paper, we show that a fully operational robotic platform must address the integration of many inter-disciplinary components and methods within tight real-time, technological and physiological constraints. We also concluded that various types of nanorobots with different dimensions and characteristics will most likely also be required to navigate effectively in the complex network comprised of various diameter blood vessels and flow rates. This will prove to be more important as we attempt to enhance the targeting effectiveness in the microvasculature system, when such nanorobots will need to transit through larger diameter vessels in the human blood network. Through experimental results and theoretical formulations, we also showed the advantages of integrating biological components, and more specifically MTB, for the development of hybrid (made of synthetic and biological components) nanorobots adapted to operate in the human microvasculature system. We also showed methods of directional and velocity controls and demonstrated that some behaviors and characteristics of the MTB can be altered. More important is the fact that all of these methods can be controlled from an electronic system. Finally, an imaging modality to track the bacterial nanorobots has been proposed and validated with a clinical MRI system, allowing closedloop navigation control of the medical nanorobots by computer towards specific destinations in the human body.
